226 related articles for article (PubMed ID: 36170819)
1. A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation.
Drozdz MM; Doane AS; Alkallas R; Desman G; Bareja R; Reilly M; Bang J; Yusupova M; You J; Eraslan Z; Wang JZ; Verma A; Aguirre K; Kane E; Watson IR; Elemento O; Piskounova E; Merghoub T; Zippin JH
Cell Rep; 2022 Sep; 40(13):111412. PubMed ID: 36170819
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL
Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589
[TBL] [Abstract][Full Text] [Related]
3. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes.
Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS
EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
Fan R; Kim NG; Gumbiner BM
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
[TBL] [Abstract][Full Text] [Related]
5. Regulation of YAP by mechanical strain through Jnk and Hippo signaling.
Codelia VA; Sun G; Irvine KD
Curr Biol; 2014 Sep; 24(17):2012-7. PubMed ID: 25127217
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
8. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP.
Hong AW; Meng Z; Yuan HX; Plouffe SW; Moon S; Kim W; Jho EH; Guan KL
EMBO Rep; 2017 Jan; 18(1):72-86. PubMed ID: 27979971
[TBL] [Abstract][Full Text] [Related]
9. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ.
Kwon H; Kim J; Jho EH
FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335
[TBL] [Abstract][Full Text] [Related]
10. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
11. Spatial modeling reveals nuclear phosphorylation and subcellular shuttling of YAP upon drug-induced liver injury.
Wehling L; Keegan L; Fernández-Palanca P; Hassan R; Ghallab A; Schmitt J; Tang Y; Le Marois M; Roessler S; Schirmacher P; Kummer U; Hengstler JG; Sahle S; Breuhahn K
Elife; 2022 Oct; 11():. PubMed ID: 36255405
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.
Han H; Qi R; Zhou JJ; Ta AP; Yang B; Nakaoka HJ; Seo G; Guan KL; Luo R; Wang W
Mol Cell; 2018 Oct; 72(2):328-340.e8. PubMed ID: 30293781
[TBL] [Abstract][Full Text] [Related]
13. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization.
Moon S; Kim W; Kim S; Kim Y; Song Y; Bilousov O; Kim J; Lee T; Cha B; Kim M; Kim H; Katanaev VL; Jho EH
EMBO Rep; 2017 Jan; 18(1):61-71. PubMed ID: 27979972
[TBL] [Abstract][Full Text] [Related]
15. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
[TBL] [Abstract][Full Text] [Related]
16. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
17. Oxford and the Savannah: can the hippo provide an explanation for Peto's paradox?
Kelleher FC; O'Sullivan H
Clin Cancer Res; 2014 Feb; 20(3):557-64. PubMed ID: 24166913
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
19. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
20. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
